Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA.

Dr. George Simon on Individualizing Treatment Recommendations in Advanced NSCLC using Molecular Factors
Sun, 12/20/2009 - 07:27
Author
Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services, Founder, President and CEO of GRACE

Dr. George Simon, medical oncologist and Director of the Thoracic Oncology Program at Fox Chase Cancer Center in Philadelphia, has been kind enough to sit down for an interview with me earlier this year, which was made into a podcast several months ago. More recently, he participated in our NSCLC Patient Education, sponsored by OSI Pharmaceuticals and Swedish Cancer Institute, where asked him to speak on molecular factors that are emerging to help us individualize our treatment recommendations for advanced NSCLC. Much of his work over the last few years has been on proteins like ERCC1, RRM1, and others that may allow us to hone our treatment plans with chemotherapy, and he also has a significant interest in molecular markers that are emerging as increasingly relevant with targeted therapies like EGFR inhibitors.

His brief introduction to the field is included here, with the audio and video versions of the podcast, as well as the accompanying set of figures and the transcript from his presentation.

[powerpress]

simon-individualizing-rx-adv-nsclc-molec-factors-audio-podcast

simon-individualizing-rx-adv-nsclc-molec-factors-figs

simon-individualizing-rx-adv-nsclc-molec-factors-transcript

Although this work with molecular factors for selecting optimal chemotherapy isn't at the point yet where I or many of the other faculty members here would be inclined to use it routinely off protocol, I do think it's very promising work that could lead to refinements in how we can achieve better outcomes with our patients over the next few years even with the tools we have available today. And the important prospective trials are underway that could lead to changes in how we approach chemotherapy for advanced NSCLC in the near future.

I hope it's helpful. Our next podcast, which we'll aim to put out just before Christmas, will finish out the program from the NSCLC Patient Education Forum and will feature Dr. Julie Brahmer on Treatment after First Line for Advanced NSCLC: What Drugs and When?

Next Previous link

Previous PostNext Post

Forum Discussions

Hi JW and welcome to Grace. I'm sorry you're going through this but hopefully and probably this isn't cancer. There is so much going on anatomically in that area that the...

Hi and welcome to Grace. I'm so sorry about your mom's situation, it's very complicated and not at all reasonable for us to comment on all that is being taken into...

Hi Scruboak, I will ask Dr. West to comment, it may be tomorrow. He's an expert in the field and will have thoughtful input. The fact that it was caught and...

I asked Dr. West and he said that this is a question he can't answer, we don't have studies that give details that specific. He said to his knowledge, that this...

Thank you so much, Janine. It helps me to just chill overall.

It's surprising how a little piece of intel can make everything else in life easier.

Hi Scrappy,


 


Below I've pasted my comment from facebook. Google is a double-edged sword, you can find anything but without some context, it can be tough to digest. We get...

Recent Comments

JOIN THE CONVERSATION
Hi JW and welcome to Grace. …
By JanineT Forum … on Mon, 05/16/2022 - 10:52
All's good
By JanineT Forum … on Sat, 05/14/2022 - 15:10
Can Pancoast affect both sides of the body?
By JanineT Forum … on Wed, 05/11/2022 - 19:49
Hi and welcome to Grace. I…
By JanineT Forum … on Sun, 04/24/2022 - 08:41